Cargando…
Carbamazepine and psychotherapy in the treatment of schizoaffective psychosis.
The authors describe the interactions between and the differential effects of carbamazepine and individual psychotherapy in the treatment of a schizoaffective patient. Carbamazepine's impact on the patient's affective life facilitated the establishment of a working alliance in psychotherap...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Yale Journal of Biology and Medicine
1985
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2589917/ https://www.ncbi.nlm.nih.gov/pubmed/4049914 |
_version_ | 1782161211451768832 |
---|---|
author | Cegalis, J. A. Possick, S. G. |
author_facet | Cegalis, J. A. Possick, S. G. |
author_sort | Cegalis, J. A. |
collection | PubMed |
description | The authors describe the interactions between and the differential effects of carbamazepine and individual psychotherapy in the treatment of a schizoaffective patient. Carbamazepine's impact on the patient's affective life facilitated the establishment of a working alliance in psychotherapy. As the patient began to understand and differentiate aspects of his affective, cognitive, bodily, and interpersonal experiences, his life situation stabilized and his carbamazepine dose requirements diminished. |
format | Text |
id | pubmed-2589917 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1985 |
publisher | Yale Journal of Biology and Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-25899172008-11-28 Carbamazepine and psychotherapy in the treatment of schizoaffective psychosis. Cegalis, J. A. Possick, S. G. Yale J Biol Med Research Article The authors describe the interactions between and the differential effects of carbamazepine and individual psychotherapy in the treatment of a schizoaffective patient. Carbamazepine's impact on the patient's affective life facilitated the establishment of a working alliance in psychotherapy. As the patient began to understand and differentiate aspects of his affective, cognitive, bodily, and interpersonal experiences, his life situation stabilized and his carbamazepine dose requirements diminished. Yale Journal of Biology and Medicine 1985 /pmc/articles/PMC2589917/ /pubmed/4049914 Text en |
spellingShingle | Research Article Cegalis, J. A. Possick, S. G. Carbamazepine and psychotherapy in the treatment of schizoaffective psychosis. |
title | Carbamazepine and psychotherapy in the treatment of schizoaffective psychosis. |
title_full | Carbamazepine and psychotherapy in the treatment of schizoaffective psychosis. |
title_fullStr | Carbamazepine and psychotherapy in the treatment of schizoaffective psychosis. |
title_full_unstemmed | Carbamazepine and psychotherapy in the treatment of schizoaffective psychosis. |
title_short | Carbamazepine and psychotherapy in the treatment of schizoaffective psychosis. |
title_sort | carbamazepine and psychotherapy in the treatment of schizoaffective psychosis. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2589917/ https://www.ncbi.nlm.nih.gov/pubmed/4049914 |
work_keys_str_mv | AT cegalisja carbamazepineandpsychotherapyinthetreatmentofschizoaffectivepsychosis AT possicksg carbamazepineandpsychotherapyinthetreatmentofschizoaffectivepsychosis |